Rockefeller Capital Management’s Kura Oncology KURA Stock Holding History

Rockefeller Capital Management’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.89K	Sell	719 -781	-52%	-$7.37K	﹤0.01%	4101
2026 Q1	$12.2K	Buy	1,500 +904	+152%	+$7.77K	﹤0.01%	3909
2025 Q4	$6.19K	Buy	+596	New	+$6.25K	﹤0.01%	3999
2023 Q1	–	Sell	-26	Closed	–	–	3028
2022 Q4	$0	Sell	26 -111	-81%	-$1.61K	﹤0.01%	4051
2022 Q3	$1K	Sell	137 -336	-71%	-$5.18K	﹤0.01%	3742
2022 Q2	$8K	Buy	473 +447	+1,719%	+$6.43K	﹤0.01%	3235
2022 Q1	$0	Hold	26	–	–	﹤0.01%	3978
2021 Q4	$0	Buy	+26	New	+$421	﹤0.01%	3886
2021 Q3	–	Sell	-29	Closed	–	–	3765
2021 Q2	$0	Buy	+29	New	+$720	﹤0.01%	3524

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACM

Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Rockefeller Capital Management's KURA Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Kura Oncology (KURA) stake by 52% in Q2 2026, selling an estimated $7.37K and leaving 719 shares worth $7.89K. The position accounts for ﹤0.01% of the portfolio, ranked #4101.

Rockefeller Capital Management first reported a position in KURA in Q2 2021 and has held it in 9 quarters since. The position peaked at $12.2K in Q1 2026. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

Rockefeller Capital Management held 719 shares of Kura Oncology worth $7.89K as of Q2 2026.
Rockefeller Capital Management sold 781 Kura Oncology shares in Q2 2026, an estimated $7.37K.
Kura Oncology made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4101 holding.
Rockefeller Capital Management first reported a position in Kura Oncology in Q2 2021 and has held it in 9 quarters since.
Rockefeller Capital Management's Kura Oncology position peaked at $12.2K in Q1 2026.
221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.